Pharmaceutical

Lynk Pharmaceuticals announced the launch of the first patient in the Phase I clinical study of its triple kinase inhibitor LNK01002

HANGZHOU, China, August 12, 2021 / PRNewswire / – Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as “Lynk Pharmaceuticals”), an innovative drug development company, today announced that it has administered its triple kinase inhibitor LNK01002 to the first patient in a Phase I clinical trial. This is an open-label, multicenter, …

Read More »

Intercept Pharmaceuticals announces convertible note swap, new issue and repurchase of shares

NEW YORK, Aug. 10, 2021 (GLOBE NEWSWIRE) – Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) (“Intercept”), a biopharmaceutical company focused on the development and commercialization of novel therapies to treat progressive non-viral liver disease, announced today that it has entered into privately negotiated agreements with some of the holders of its (i) …

Read More »

West Pharmaceutical Services Expands Williamsport, Pa. Plant

Related research West Pharmaceutical Services, Inc., one of the world’s leading manufacturers of the design and production of high-quality delivery systems for injectable drugs, will expand and modernize its manufacturing facility in Williamsport, Pennsylvania. The $ 18 million project is expected to retain 1,100 jobs statewide and create more than …

Read More »

National Institute of Pharmaceutical Education and Research Launches Open Access Publishing Hub in India with F1000

ANI | Updated: 05 Aug 2021 13:56 STI Calcutta (West Bengal) [India], Aug 5 (ANI / BusinessWire India): Check out the new gateway on F1000Research, to host the results of the National Institute of Pharmaceutical Education and Research (NIPER-Kolkata) conference. Today, the National Institute of Pharmaceutical Education and Research (NIPER-Kolkata) …

Read More »

Windlas Biotech IPO opens today: what you need to know

The proceeds of the IPO will be used by Windlas Biotech for the purchase of equipment necessary to expand the capacity of the Dehradun-IV plant and to add a dosing capacity for injectables. to the installation of Dehradun Plant-II. By hindustantimes.com | Edited by Amit Chaturvedi, Hindustan Times, New Delhi …

Read More »

Lee’s Pharmaceutical Announces First Patient Receiving Its Anti-PD-L1 Antibody, Socazolimab, Licensed From Sorrento Therapeutics, As First-Line Treatment For Large-Stage Small Cell Lung Cancer

China Oncology Focus, a subsidiary of Lee’s Pharm, has enrolled the first patient in the phase 3 double-blind study of Socazolimab in combination with chemotherapy as a first-line treatment for advanced small cell lung cancer. Socazolimab is an anti-PD-L1 antibody licensed from Sorrento for the Greater China Territory by Lee’s …

Read More »

Robeson County is in line for millions of dollars in settlement with drug companies

LUMBERTON – Robeson County and its municipalities could receive millions of dollars from the $ 26 billion national opioid settlement reached Wednesday that aims to reduce opioid dependence and hold manufacturers and distributors accountable. The deal was made with Cardinal, McKesson and AmerisourceBergen – the country’s three largest pharmaceutical distributors …

Read More »